I'm pretty sure in the webinar Nigel indicated breakeven by end CY 2025. On current spend, he implies revenue of 2.5 million in the second quarter of FY 2026
Ann: 200th patient treated with the OncoSil device, page-33
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
-0.001(3.57%) |
Mkt cap ! $51.08M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.4¢ | 1.3¢ | $10.95K | 818.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 6877744 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 6707716 | 19 |
View Market Depth
| Last trade - 14.41pm 18/09/2024 (20 minute delay) ? |
| OSL (ASX) Chart |